Medication info
Damosidil Tablet (Minoxidil)

Damosidil Tablet (Minoxidil)

Prescription medicationTabletOral
Ingredient · strength
Minoxidil›5mg / 1 tablet
Manufacturer / importer
NovaM Healthcare Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 202501377 · Approved 2025.06.04

Summary

Main use
Treatment of hypertension (e.g., resistant or symptomatic hypertension)
Who takes it
Adults · Children
Adult dose
Adults (12 years and older): The initial dose is 5 mg of minoxidil orally once daily; the maintenance dose is 10 - 40 mg daily in 1 - several divided doses. Up to 100 mg may be administered daily. Frequency of administration: During treatment with this medicine, the magnitude of fluctuations in arterial blood pressure over the course of a day is proportional to the amount of blood pressure reduction. If the decrease in diastolic blood pressure is less than 30 mmHg, once-daily administration is acceptable; if it is 30 mmHg or greater, administer in 2 divided doses daily. Dose adjustment: The dose should be determined carefully according to the patient's response. When adjusting the dose, allow an interval of at least 3 days, as an adequate response to a dose may take 3 days or longer to appear. If more rapid treatment of hypertension is required, the dose may be adjusted every 6 hours while the patient is carefully monitored. Concomitant administration Diuretics: This medicine is administered with a diuretic in patients who rely on renal function to maintain salt and water balance. It has been administered concomitantly with the following diuretics: ① Hydrochlorothiazide (50 mg per dose twice daily) or another thiazide diuretic (equivalent effective dose) ② Chlorthalidone (50 - 100 mg per dose once daily) ③ Furosemide (40 mg per dose twice daily) If excessive salt and water retention causes a weight gain of approximately 1.8 kg or more, the diuretic should be changed to furosemide. If the patient is already receiving furosemide, increase the dose as needed. β-blockers or other sympatholytic agents: When this medicine is administered, administer a β-blocker in divided doses equivalent to propranolol 80 - 160 mg daily. If β-blockers are contraindicated, methyldopa (250 - 750 mg per dose twice daily) may be used instead. Since methyldopa takes time to exert its effect, administer it at least 24 hours before starting this medicine. The dose may be adjusted as appropriate according to age and symptoms.
Child dose
Children (12 years and younger): The initial dose is 0.2 mg/kg once daily. The dose may be increased by 50 - 100 % until blood pressure is optimally controlled. The maintenance dose is 0.25 mg - 1.0 mg/kg daily. Up to 50 mg may be administered daily.

Ingredients

Manufacturer
NovaM Healthcare Co., Ltd.

Efficacy & effects

Treatment of hypertension (e.g., resistant or symptomatic hypertension)

  • Hypertension
  • resistant hypertension
View approved original text

This medication is used for symptomatic hypertension, which occurs due to specific diseases or organ damage. It is also effective in treating resistant hypertension that does not respond to diuretics and two types of antihypertensive agents. It helps manage difficult hypertension to stabilize blood pressure effectively.

How to take

Adult dose

Adults (12 years and older): The initial dose is 5 mg of minoxidil orally once daily; the maintenance dose is 10 - 40 mg daily in 1 - several divided doses. Up to 100 mg may be administered daily. Frequency of administration: During treatment with this medicine, the magnitude of fluctuations in arterial blood pressure over the course of a day is proportional to the amount of blood pressure reduction. If the decrease in diastolic blood pressure is less than 30 mmHg, once-daily administration is acceptable; if it is 30 mmHg or greater, administer in 2 divided doses daily. Dose adjustment: The dose should be determined carefully according to the patient's response. When adjusting the dose, allow an interval of at least 3 days, as an adequate response to a dose may take 3 days or longer to appear. If more rapid treatment of hypertension is required, the dose may be adjusted every 6 hours while the patient is carefully monitored. Concomitant administration Diuretics: This medicine is administered with a diuretic in patients who rely on renal function to maintain salt and water balance. It has been administered concomitantly with the following diuretics: ① Hydrochlorothiazide (50 mg per dose twice daily) or another thiazide diuretic (equivalent effective dose) ② Chlorthalidone (50 - 100 mg per dose once daily) ③ Furosemide (40 mg per dose twice daily) If excessive salt and water retention causes a weight gain of approximately 1.8 kg or more, the diuretic should be changed to furosemide. If the patient is already receiving furosemide, increase the dose as needed. β-blockers or other sympatholytic agents: When this medicine is administered, administer a β-blocker in divided doses equivalent to propranolol 80 - 160 mg daily. If β-blockers are contraindicated, methyldopa (250 - 750 mg per dose twice daily) may be used instead. Since methyldopa takes time to exert its effect, administer it at least 24 hours before starting this medicine. The dose may be adjusted as appropriate according to age and symptoms.

Child dose

Children (12 years and younger): The initial dose is 0.2 mg/kg once daily. The dose may be increased by 50 - 100 % until blood pressure is optimally controlled. The maintenance dose is 0.25 mg - 1.0 mg/kg daily. Up to 50 mg may be administered daily.

Precautions

This medication should not be used by patients with specific diseases. For example, patients with pheochromocytoma may be at risk as this medication can lower blood pressure while stimulating the secretion of catecholamines from the tumor. Additionally, patients with pulmonary hypertension caused by mitral stenosis, those with acute myocardial infarction, and patients allergic to this medication should not use it. Patients with chronic congestive heart failure, severe renal failure, and angina should exercise extra caution when using this medication. Several side effects may occur when using this medication. One of the most common side effects is hirsutism, which occurs in about 80% of patients, with hair growth or darkening appearing within 3 to 6 weeks. This symptom usually starts in the facial area and can spread throughout the body; upon discontinuation of the drug, new hair growth stops, but it may take 1 to 6 months to return to the original state. This phenomenon is not related to hormonal abnormalities, but it may pose issues particularly for children and women, so caution is necessary beforehand. There may also be skin rashes, blisters, and in severe cases, hypersensitivity reactions such as Stevens-Johnson syndrome. Blood tests may show decreased platelet or white blood cell counts, and during initial treatment, there may be a reduction in blood red cell counts. Electrocardiograms may show changes in heart electrical signals, but most often, these will resolve with ongoing treatment and do not cause any issues with heart function. Rarely, pericardial effusion, which is fluid accumulation around the heart, may occur, especially in patients with poor kidney function. In this case, ultrasound examination should be performed to check the condition, and treatment methods should be adjusted if necessary. Other symptoms can include weight gain, peripheral edema, increased heart rate, temporary elevation of kidney function indicators, gastrointestinal disturbances, rashes, breast pain, gynecomastia, anemia, headaches, nausea and vomiting, etc. When using this medication, diuretics are typically used together to prevent fluid retention and the worsening of heart failure, and weight and electrolyte status should be checked frequently. Due to vasodilatory effects, heart rate may increase or symptoms of angina may appear, so beta-blockers are often used together. Patients with renal failure or those on dialysis may require adjustment of the dosage, and myocardial infarction patients should be treated only after their condition stabilizes. In the initial stages of treatment, various tests including urine tests, kidney function tests, electrocardiograms, chest x-rays, and echocardiograms should be performed regularly. Additionally, this medication may interact with other medications. For instance, taking it with guanethidine may result in severe orthostatic hypotension, so it should be avoided if possible or only initiated in a hospital setting. Antidepressants or antipsychotics can increase the risk of hypotension, and the use of corticosteroids or tetracosactide may exacerbate fluid retention. Caution is needed when used with anti-inflammatory analgesics, as the antihypertensive effect may be reduced. The safety of this medication during pregnancy is not certain, and if breastfeeding, it should be avoided or breastfeeding should be discontinued if necessary. There is limited experience using this medication in children, especially infants, so caution should be exercised. In the case of overdose, blood pressure can drop too low, necessitating immediate hospital treatment. In this situation, normal saline infusion may be used to maintain blood pressure, and specific sympathomimetic agents should not be used to avoid excessive cardiac stimulation. Careful use of medications to aid in blood pressure recovery is recommended.

Side effects

Hirsutism, densification, hyperpigmentation, exudative rash, vesicular lesions, Stevens-Johnson syndrome, thrombocytopenia, leukopenia, decreased hematocrit, decreased hemoglobin, decreased red blood cells, increased ALP, changes in T-wave direction and amplitude on electrocardiogram, pericardial effusion, cyanosis, peripheral vascular edema, increased heart rate, elevated creatinine, increased BUN, gastrointestinal disturbances, rash, mastalgia, gynecomastia, hemolytic anemia, pulmonary infiltrates, increased antinuclear antibodies, headache, intermittent claudication, frequent menstruation, nausea, vomiting

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to keep it at room temperature, between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.